Screening for Urinary Incontinence by Primary Care Providers
NCT ID: NCT00178334
Last Updated: 2013-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
554 participants
OBSERVATIONAL
2006-03-31
2006-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Assess the rate of screening for urinary incontinence (UI) in women by their primary care providers
* Identify the type of screening used by primary care providers
* Identify barriers to screening for UI
* Identify differences in screening rates between specialties
* Assess whether primary care providers view UI as a serious medical problem
* Assess the comfort level of primary care providers in the diagnosis and treatment of UI
* Identify primary care providers' preferred mode of learning more about UI
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Burden of Urinary Incontinence in Home Care Patients in the State of Geneva
NCT00530036
In-person Focus Groups in the Management of Urinary Incontinence in Women
NCT05395793
Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence
NCT01445834
The Urinary Incontinence Treatment Study
NCT03057834
Prevent Inability To Control Urination
NCT00075114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gunhilde Buchsbaum
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gunhilde Buchsbaum, MD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11355
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.